Kyorin's Sustainability

Top Message

The Kyorin Group is working to realize the corporate philosophy “Kyorin continues to fulfill its mission of cherishing life, and benefiting society by contributing to better health“.

Based on its corporate philosophy “to cherish life and benefit society by contributing to better health,” the Group have decided to formulate a new long-term vision “Vision 110” and aim to become “a company that contributes broadly to people's health by comprehensively developing healthcare-related businesses, with a core focus on the new drug business, which continuously provides high-value new drugs that meet medical needs”.

While there are various social issues to be solved, the sustainable growth of a company (economic value) and the realization of a sustainable society through business activities (social value) are becoming more and more important. The Group develops and provides useful and safe products and services by developing a combination of the ethical drug business and the healthcare business, which are our core businesses and we will contribute to sustainable economy growth and resolution of social issues. We will also work to strengthen corporate governance in order to carry out sustainable business activities.

As part of this, we revised the Corporate Behavior Charter and Compliance Guidelines in April 2019 to further penetrate the company.

The Kyorin Group hopes to be a company that continuously contributes to the sustainable development of society and is recognized by society while communicating with stakeholders.

Your Health is Kyorin’s Mission.

KYORIN Pharmaceutical Co., Ltd.

Representative Director, President and Chief Executive Officer

Yutaka Ogihara

Basic policy on sustainability

Following our corporate philosophy, “Kyorin continues to fulfill its mission of cherishing life and benefiting society by contributing to better health,” the Kyorin group is proactively addressing sustainability issues for society’s continuous development through business activities based on our Corporate Charter, as we work to enhance corporate value over the medium to long term..

Designation of materiality

Using a matrix with one axis representing social importance and the other axis standing for importance to the Group, we have designated 10 items as materiality from among the various issues related to sustainability. We will place a priority on addressing these issues from the perspective of “value creation (issues directly connected to business activities)” and the perspective of a “base to support value creation (issues related to a base for business activities)” as we work to achieve the goals of the long-term vision “Vision 110.”

Corporate philosophy

Long-term vision
Vision 110

(Important issues)

Medium-term business plan
Vision 110 –Stage1–

Policies and plans for each fiscal year

Designation of important issues referencing social concerns

Image: Designation of important issues referencing social concerns

Value creation

  • Creating high-value products that meet medical needs
  • Maximizing value of products
  • Providing a stable supply of high-quality pharmaceutical products

Base to support value creation

  • Enhancing human capital
  • Promoting work-style reforms that respect diverse values
  • Promoting health management
  • Carrying out environmentally friendly business activities
  • Ensuring thorough compliance
  • Strengthening corporate governance
  • Strengthening relationships with stakeholders

Process for designation materiality

Materiality is designated by the following process, based on the Kyorin Group’s forward-looking environment outlook and analysis and referral to various principles and guidelines.

These issues are continuously reviewed in light of environmental changes, the Kyorin Group’s business activities and demand of society.

  1. 1. Identification of issues
    Issue are identified based on various principles and guidelines (including ISO 26000, the UN’s Sustainable Development Goals, and the materiality map for the healthcare industry formulated by the Sustainability Accounting Standards Boards,
  2. 2. Narrowing drown issues
    Identified issues are narrowed down in light of the Group’s corporate philosophy, long-term vision, etc.
  3. 3. Assignment of priority
    Issues of particularly high priority and identified using a matrix with two axes-importance to society and importance to the Group.
  4. 4. Designation of materiality
    Issue identified as important for materiality are deliberated by the Management Committee and resolved by the Board of Directors.


Corporate philosophy

Value creation

Materiality KPI Related SDGs
  • Creating high-value products that meet medical needs
  • Clinical development milestones
  • Number of in-licensed products
  • 3.Ensure healthy lives and promote well-being for all at all ages
  • 9.Build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation
  • 12.Ensure sustainable consumption and production patterns
  • 17.Strengthen the means of implementation and revitalize the Global Partnership for Sustainable Development
  • Maximizing value of products
  • Ratio of new drugs
  • Sales of main products
  • Providing a stable supply of high-quality pharmaceutical products
  • Number of stockouts
  • Number of product recalls
  • On-track progress at Takaoka Plant (qualitative)

Base to support value creation

Materiality KPI Related SDGs
  • Enhancing human capital
  • Main scores from job satisfaction surveys
  • Appropriate operation and improvement of human resources system (qualitative)
  • 5.Achieve gender equality and empower all women and girls
  • 8.Promote sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all
  • Promoting work-style reforms that respect diverse values
  • Percentage of management positions filled by women
  • Percentage of male employees taking childcare leave
  • Percentage of employees with disabilities
  • Promoting health management
  • Percentage of employees undergoing health examinations and stress checks
  • Carrying out environmentally friendly business activities
  • Percentage reduction of CO2emissions
  • 7.Ensure access to affordable, reliable, sustainable and modern energy for all
  • 12.Ensure sustainable consumption and production patterns
  • 13.Take urgent action to combat climate change and its impacts
  • 15.Protect, restore and promote sustainable use of terrestrial ecosystems, sustainably manage forests, combat desertification, and halt and reverse land degradation and halt biodiversity loss
  • Ensuring thorough compliance
  • Number of signifi cant compliance violations
  • 16.Promote peaceful and inclusive societies for sustainable development, provide access to justice for all and build effective, accountable and inclusive institutions at all levels
  • Strengthening corporate governance
  • Appropriate response to Corporate Governance Code (qualitative)
  • Strengthening relationships with stakeholders
  • Stronger engagement with investors (qualitative)

Corporate Charter

  1. 1Contribute to sustainable economic growth and to the resolution of social issues
  2. 2Rigorous and scientific research and development
  3. 3Promotion of appropriate use of drugs
  4. 4Relationships of trust with medical professionals, patients, etc.
  5. 5Fair business practices
  6. 6Thorough information management
  7. 7Fair information disclosure and constructive dialogue with stakeholders
  8. 8Work-style reforms and improvement of work environments
  9. 9Initiatives to tackle environmental issues
  10. 10Co-exist with society and contribute to society’s development
  11. 11Comprehensive crisis management
  12. 12Respect for human rights
  13. 13Stringent implementation by Company officers of their responsibilities and the charter

Relationships with stakeholders

Image: Relationships with stakeholders

SDGs (Sustainable Development Goals)

The SDGs are a series of international goals targeted for achievement by 2030 adopted at the 2015 United Nations Summit. The Kyorin Group has incorporated these goals into its business practices and eff orts to co-exist with society, and works to contribute to the realization of a sustainable society.

Image: SDGs (Sustainable Development Goals)